Ocugen Inc. Announces Inducement Grants
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced the Compensation Committee of the Board of Directors of Ocugen recently approved the grant of stock options to purchase an aggregate of …
Read MoreNASDAQ
Are you looking for Chester County businesses that are traded on the Nasdaq Stock Market? Would you love adding a Chester County business to your investment portfolio or 401k? The process of building a properly diversified portfolio, which includes investments in local businesses, is an important personal financial strategy.
Here you will find news and updates from Chester County businesses that are listed on the Nasdaq Stock Market. There is a growing appetite for real, local business news about publicly traded companies. MyChesCo features local business news from around Chester County. Moreover, we provide in-depth articles about Chester County’s dynamic business and economic scene, including tips for small biz owners, marketing, management, startups, entrepreneurship, and more.
Trevena to Present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech Summit
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the Oppenheimer 2021 Fall Healthcare Life Sciences & MedTech …
Read More
Baudax Bio to Participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX) announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will participate in a virtual fireside chat at the Oppenheimer Fall …
Read More
Galera to Host Virtual Key Opinion Leader Event on Radiotherapy-Induced Severe Oral Mucositis (SOM) in Patients with Head and Neck Cancer
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced that the Company will host a virtual Key Opinion Leader event on radiotherapy-induced severe oral mucositis (SOM) in patients with head …
Read More
Zynerba Pharmaceuticals Initiates RECONNECT, a Pivotal Phase 3 Trial of Zygel in Fragile X Syndrome
DEVON, PA — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE) announced the initiation of a pivotal, multinational randomized, double-blind, placebo-controlled, multiple-center, efficacy and safety (RECONNECT) Phase 3 trial.
Read More
TELA Bio Announces New Data on Use of OviTex in a Range of Hernia Repair Applications
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) announced details of the clinical research presented last week at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) meeting in Las …
Read More Trevena to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN) announced that Carrie Bourdow, President and Chief Executive Officer of Trevena, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held …
Read More Galera Announces Final Results from Pancreatic Cancer Trial
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) announced final results from its Phase 1/2 pilot trial of its dismutase mimetic, GC4419, versus placebo, in patients with unresectable or borderline …
Read More Ocugen, Inc. to Present at Upcoming Citi and H.C. Wainwright Investment Conferences
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that it will be participating in Citi’s 16th Annual BioPharma Virtual Conference being held on September 8-10, 2021 and at the H.C. …
Read More
Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) and Zion Healing, Inc. announced a new agreement under which Neuronetics will be the exclusive supplier of TMS equipment to Zion Healing, Inc. …
Read More